9-(b-D-Arabinofuranosyl)hypoxanthine
CAS: 7013-16-3
Ref. 3D-NA03401
| 1g | 271.00 € | ||
| 2g | 447.00 € | ||
| 5g | 732.00 € | ||
| 10g | 1,276.00 € | ||
| 500mg | 180.00 € |
Product Information
- Arabinofuranosyl-hypoxanthine
- 6H-Purin-6-one, 9-beta-D-arabinofuranosyl-1,9-dihydro-
- 6H-Purin-6-one, 9-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-1,9-dihydro-
- 9-(b-D-Arabinofuranosyl) hypoxanthine
- 9-(beta-D-Arabinofuranosyl)hypoxanthine
- 9-(beta-D-arabinofuranosyl)-3,9-dihydro-6H-purin-6-one
- 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purin-6-one
- 9-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-1,9-dihydro-6H-purin-6-one
- 9-β-<span class="text-smallcaps">D</span>-Arabinofuranosylhypoxanthine
- Ara-H
- See more synonyms
- Arabinosylhypoxanthine
- Arainosine
- Hypoxanthine arabinoside
- Hypoxanthine, 9-beta-D-arabinofuranosyl-
- Hypoxanthine, 9-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-
- Hypoxanthine-9-Beta-D-Arabinofuranoside
- Nsc 405122
9-(b-D-Arabinofuranosyl)hypoxanthine is a glycosylated analogue of the incretin hormone glucagon-like peptide-1 (GLP-1). It has been shown to inhibit Streptococcus pyogenes and other bacteria. 9-(b-D-Arabinofuranosyl)hypoxanthine has also been shown to have inhibitory properties against zirconium oxide, pulmonary vasodilation, squamous cell carcinoma, and rate constant. This drug has not been studied in clinical trials for antiviral prophylaxis or arabinoside. The only known side effects are drug interactions with cyclin D2 and nitrate reductase.
Chemical properties
Technical inquiry about: 3D-NA03401 9-(b-D-Arabinofuranosyl)hypoxanthine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
